• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分期迁移视角下重新评估腹腔镜肝切除术治疗中期肝细胞癌的优势:倾向评分分析差异获益。

Reappraisal of the advantages of laparoscopic liver resection for intermediate hepatocellular carcinoma within a stage migration perspective: Propensity score analysis of the differential benefit.

机构信息

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milano, Italy.

出版信息

J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):510-521. doi: 10.1002/jhbp.736. Epub 2020 Apr 16.

DOI:10.1002/jhbp.736
PMID:32189450
Abstract

OBJECTIVE

The aim of the present study was to analyze the outcome of laparoscopic approach specifically in patients with Intermediate-stage disease and to define the differential benefit with Early-stage patients.

METHODS

Six hundred twenty-two resections for HCC were dichotomized according to staging (Early and Intermediate) and to approach and then matched in a 1:1 ratio using propensity scores to obtain four groups (E-MILS and E-Open, including 104 patients respectively; Int-MILS and Int-Open, including 142 patients, respectively). The differential benefit associated with the minimally invasive technique was evaluated between intermediate-stage and early-stage patients taking into account blood loss and morbidity rate as outcome indicators.

RESULTS

Laparoscopic approach resulted in a statistically significant lower blood loss, reduced morbidity, reduced incidence of hepatic decompensation and shorter time for functional recover and length of stay. The evaluation of the differential benefit showed a greater advantage of laparoscopic approach in Intermediate-stage patients compared with Early-stage patients, both in terms of blood loss and morbidity rate.

CONCLUSIONS

The favorable biological scenario associated with laparoscopic approach allows to obtain enhanced benefits in the setting of more advanced liver disease. The push towards minimal invasiveness and the incremental benefit associated with it could potentially promote stage migration in suitable patients.

摘要

目的

本研究旨在分析腹腔镜方法在中危期患者中的治疗效果,并确定与早期患者相比的差异获益。

方法

根据分期(早期和中危期)和方法将 622 例 HCC 切除术分为两组,然后使用倾向评分进行 1:1 配对,得到四组(E-MILS 和 E-Open,分别包括 104 例患者;Int-MILS 和 Int-Open,分别包括 142 例患者)。考虑到出血量和并发症发生率作为结果指标,评估微创技术与中危期和早期患者相关的差异获益。

结果

腹腔镜方法在出血量、并发症发生率、肝功能失代偿发生率、功能恢复时间和住院时间方面具有统计学显著优势。评估差异获益显示,腹腔镜方法在中危期患者中比早期患者具有更大的优势,无论是在出血量还是并发症发生率方面。

结论

腹腔镜方法相关的有利生物学情况可在更严重的肝病患者中获得更大的获益。向微创化推进及其相关的增量获益可能会促使适合的患者分期迁移。

相似文献

1
Reappraisal of the advantages of laparoscopic liver resection for intermediate hepatocellular carcinoma within a stage migration perspective: Propensity score analysis of the differential benefit.基于分期迁移视角下重新评估腹腔镜肝切除术治疗中期肝细胞癌的优势:倾向评分分析差异获益。
J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):510-521. doi: 10.1002/jhbp.736. Epub 2020 Apr 16.
2
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.腹腔镜与开腹肝切除术治疗伴有 Child-Pugh B 级肝硬化的肝细胞癌:多中心倾向评分匹配研究。
Br J Surg. 2021 Mar 12;108(2):196-204. doi: 10.1093/bjs/znaa041.
3
Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.倾向评分匹配下腹腔镜与开腹肝切除术治疗肝细胞癌的长期及围手术期结局:一项多机构日本研究
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):721-7. doi: 10.1002/jhbp.276. Epub 2015 Jul 1.
4
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.腹腔镜肝切除术:肝硬化和门静脉高压患者的优势是什么?系统评价和荟萃分析及个人经验。
J Laparoendosc Adv Surg Tech A. 2020 Oct;30(10):1054-1065. doi: 10.1089/lap.2020.0408. Epub 2020 Jul 20.
5
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma.腹腔镜或开腹肝切除术治疗肝细胞癌的结果的倾向评分分析。
Br J Surg. 2016 Jun;103(7):871-80. doi: 10.1002/bjs.10137. Epub 2016 Mar 31.
6
Have we really understood when the efforts of laparoscopic liver resection are justified?-a complexity-based appraisal of the differential benefit.我们真的理解了腹腔镜肝切除术的努力在何时是合理的吗?——基于复杂性的差异获益评估。
Hepatobiliary Surg Nutr. 2022 Jun;11(3):363-374. doi: 10.21037/hbsn-20-562.
7
Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approach.腹腔镜肝切除术通过减轻术后炎症反应增强肝硬化小肝细胞癌的恢复:与传统开腹手术的倾向评分匹配分析。
Surg Endosc. 2021 Feb;35(2):910-920. doi: 10.1007/s00464-020-07710-5. Epub 2020 Aug 3.
8
Laparoscopic Hepatectomy (with or without Robotic Assistance) versus Radiofrequency Ablation as a Minimally Invasive Treatment for Very Early-Stage or Early-Stage Hepatocellular Carcinoma.腹腔镜肝切除术(有或无机器人辅助)与射频消融作为极早期或早期肝细胞癌的微创治疗方法的比较。
Dig Surg. 2020;37(1):65-71. doi: 10.1159/000497112. Epub 2019 Mar 27.
9
Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a multi-centre propensity score-based analysis.腹腔镜与开腹肝切除术治疗老年肝细胞癌的多中心倾向评分分析。
Surg Endosc. 2020 Feb;34(2):658-666. doi: 10.1007/s00464-019-06812-z. Epub 2019 May 15.
10
Laparoscopic liver resection for hepatocellular carcinoma: ten-year experience in a single center.腹腔镜下肝癌切除术:单中心十年经验
Arch Surg. 2009 Feb;144(2):143-7; discussion 148. doi: 10.1001/archsurg.2008.536.

引用本文的文献

1
Augmented reality improving intraoperative navigation in minimally invasive liver surgery: an interplay between 3D reconstruction and indocyanine green.增强现实技术提高微创肝手术中的术中导航:三维重建与吲哚菁绿的相互作用。
Updates Surg. 2024 Nov;76(7):2701-2708. doi: 10.1007/s13304-024-01857-9. Epub 2024 May 2.
2
The efforts are worth the benefits for laparoscopic liver resection.对于腹腔镜肝切除术而言,这些努力带来的益处是值得的。
Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):813-814. doi: 10.21037/hbsn-23-430. Epub 2023 Sep 13.
3
A "cui prodest" evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies.
对微创肝外科手术项目发展的“谁受益”评估:左、右半肝切除术开腹与腹腔镜入路的差异化获益分析。
Surg Endosc. 2023 Nov;37(11):8204-8213. doi: 10.1007/s00464-023-10382-6. Epub 2023 Aug 30.
4
Ten years of Italian mini-invasiveness: the I Go MILS registry as a tool of dissemination, characterization and networking.十年的意大利微创探索:I Go MILS 登记作为传播、特征和网络构建的工具。
Updates Surg. 2023 Sep;75(6):1457-1469. doi: 10.1007/s13304-023-01597-2. Epub 2023 Jul 24.
5
Minimally invasive surgery and liver transplantation: is it a safe, feasible, and effective approach?微创外科与肝移植:是否安全、可行且有效?
Updates Surg. 2023 Jun;75(4):807-816. doi: 10.1007/s13304-023-01506-7. Epub 2023 Apr 4.
6
Have we really understood when the efforts of laparoscopic liver resection are justified?-a complexity-based appraisal of the differential benefit.我们真的理解了腹腔镜肝切除术的努力在何时是合理的吗?——基于复杂性的差异获益评估。
Hepatobiliary Surg Nutr. 2022 Jun;11(3):363-374. doi: 10.21037/hbsn-20-562.
7
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes.腹腔镜肝内胆管癌手术:聚焦肿瘤学结局
J Clin Med. 2021 Jun 26;10(13):2828. doi: 10.3390/jcm10132828.
8
Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.微创治疗肝门部胆管癌的围手术期和肿瘤学结局的系统评价。
Updates Surg. 2021 Apr;73(2):359-377. doi: 10.1007/s13304-021-01006-6. Epub 2021 Feb 22.